SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 9.240-5.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jmhollen who wrote (482)10/17/2006 6:20:44 PM
From: Mike McFarlandRead Replies (1) of 557
 
shame on me, the article is even older than
I thought--from '99
forbes.com
In 1992 Parker took on the risky sector of gene therapy
when she spun Targeted Genetics out of Immunex. Her colleagues
credit her with Targeted Genetics' survival; it's one of only
two of the original gene therapy pure plays to last through
the decade.


Seven years later they're still alive, remarkable.

also

Most of those who know Rathmann well are betting he will be as successful with his second startup as he was with his first


well, as I said, the article needs updating.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext